In line with our findings, HJURP expression has been reported in prostate cancer to be predominantly cytoplasmic [26,29], the hepatocellular carcinomas also display a cytoplasmic expression [30,31], whereas in gliomas, HJURP immunoreactivity is observed both in the nucleus and in the cytoplasm [32]. The gene discussed is HJURP; the disease is glioma.